{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:23Z","timestamp":1792782683769,"version":"4.5.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis Egyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Semmelweis University","id":[{"id":"https:\/\/ror.org\/01g9ty582","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>IgA vasculitis nephritis (IgAVN) develops in 20\u201380% of patients with IgA vasculitis (IgAV), yet diagnosis is often delayed. Readily available biomarkers can help identify patients at risk earlier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To conduct a systematic review and meta-analysis of all available serum and urinary biomarkers to evaluate their prognostic potential in predicting IgAVN in paediatric patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>A comprehensive search was performed in PubMed, EMBASE and Cochrane Library on November 9, 2024, covering publications from inception. The search strategy included three domains: paediatric population, IgAV diagnosis and studied biomarkers. No language or additional restrictions were applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study eligibility criteria and participants<\/jats:title>\n                    <jats:p>We included original retrospective, prospective and cross-sectional studies that involved paediatric IgAV patients and reported biomarker levels in patients with and without nephritis. Two reviewers independently screened studies, and a third reviewer resolved conflicts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study appraisal and synthesis methods<\/jats:title>\n                    <jats:p>Data extraction was performed by two independent reviewers. A random-effects model was used for analysis. The review followed PRISMA guidelines, and study quality was assessed using the QUIPS tool. Outcomes were reported as mean or standardised mean differences with 95% confidence intervals (CI). Where possible, odds ratios (OR) and diagnostic performance measures were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 10,611 records screened, 129 studies including 23,726 patients were included. The neutrophil-to-lymphocyte ratio (NLR) was significantly higher in patients with nephritis (0.48; 95% CI 0.04\u20130.93), with notable effects in the Turkish population (0.86; 95% CI 0.19\u20131.52) but not in the Chinese population (\u2212 0.02; 95% CI \u2212 0.75\u20130.72). The platelet-to-lymphocyte ratio (PLR) showed a similar pattern, being higher in the Turkish subgroup (21.9; 95% CI 9.64\u201334.16) and lower in the Chinese subgroup (\u2212 6.75; 95% CI \u2212 11.27\u20132.22). A positive faecal occult blood test (FOBT) was associated with increased odds of kidney involvement (OR 2.04; 95% CI 1.05\u20133.96).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>This study has limitations, including the predominance of retrospective data, limited reporting of diagnostic accuracy metrics (e.g. sensitivity, specificity), and substantial inter-study heterogeneity in nephritis definitions, measurement methods and study populations, which restrict firm conclusions about biomarker performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and implications of key findings<\/jats:title>\n                    <jats:p>While statistically significant biomarker associations exist, clinically actionable predictors of IgAVN remain lacking. NLR, PLR and FOBT warrant prospective validation in multicentre cohorts with standardised protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration number<\/jats:title>\n                    <jats:p>CRD42024593928.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00467-026-07382-8","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:27:36Z","timestamp":1780662456000},"page":"4379-4392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biomarkers of kidney involvement in paediatric IgA vasculitis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7776-5427","authenticated-orcid":false,"given":"M\u0103d\u0103lina Andreea","family":"Beldie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rk Viktor","family":"Hern\u00e1df\u0151i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Krisztina","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra Luca","family":"Bod\u00f3cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"L\u00f3di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliana Magdalena","family":"St\u00e2rcea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"7382_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-024-06502-6","volume":"40","author":"M Vivarelli","year":"2025","unstructured":"Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D et al (2025) IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol 40:533\u2013569","journal-title":"Pediatr Nephrol"},{"key":"7382_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00281-021-00874-9","volume":"43","author":"E Pillebout","year":"2021","unstructured":"Pillebout E, Sunderk\u00f6tter C (2021) IgA vasculitis. Semin Immunopathol 43:729\u2013738","journal-title":"Semin Immunopathol"},{"key":"7382_CR3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/adc.2005.074641","volume":"90","author":"H Narchi","year":"2005","unstructured":"Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916\u2013920","journal-title":"Arch Dis Child"},{"key":"7382_CR4","volume":"11","author":"H Chan","year":"2016","unstructured":"Chan H, Tang YL, Lv XH, Zhang GF, Wang M, Yang HP et al (2016) Risk factors associated with renal involvement in childhood Henoch-Sch\u00f6nlein purpura: a meta-analysis. PLoS One 11:e0167346","journal-title":"PLoS ONE"},{"key":"7382_CR5","volume":"14","author":"D Shi","year":"2019","unstructured":"Shi D, Chan H, Yang X, Zhang G, Yang H, Wang M et al (2019) Risk factors associated with IgA vasculitis with nephritis (Henoch-Sch\u00f6nlein purpura nephritis) progressing to unfavorable outcomes: a meta-analysis. PLoS One 14:e0223218","journal-title":"PLoS ONE"},{"key":"7382_CR6","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00467-021-05107-7","volume":"36","author":"CEC Williams","year":"2021","unstructured":"Williams CEC, Toner A, Wright RD, Oni L (2021) A systematic review of urine biomarkers in children with IgA vasculitis nephritis. Pediatr Nephrol 36:3033\u20133044","journal-title":"Pediatr Nephrol"},{"key":"7382_CR7","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"7382_CR8","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (eds)\u00a0(2024) Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane, Available from https:\/\/www.cochrane.org\/handbook. Accessed 01.11.2024"},{"key":"7382_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2046-4053-2-4","volume":"2","author":"A Booth","year":"2013","unstructured":"Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M et al (2013) PROSPERO at one year: an evaluation of its utility. Syst Rev 2:4","journal-title":"Syst Rev"},{"key":"7382_CR10","doi-asserted-by":"publisher","unstructured":"Haddaway NR, Grainger MJ, Gray CT (2021) citationchaser: an R package and shiny app for forward and backward citations chasing in academic searching (Version 0.0.3). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.4543513","DOI":"10.5281\/zenodo.4543513"},{"key":"7382_CR11","volume-title":"EndNote","author":"team TE","year":"2013","unstructured":"The Endnote team (2013) EndNote, EndNote 20 ed. Clarivate, Philadelphia, PA","edition":"EndNote 20 ed"},{"key":"7382_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan \u2014 a web and mobile app for systematic reviews. Syst Rev 5:210","journal-title":"Syst Rev"},{"key":"7382_CR13","unstructured":"[Available from: https:\/\/www.deepl.com\/en\/translator.] Accessed 12 Dec 2024"},{"key":"7382_CR14","unstructured":"Rohatgi A (2020) Webplotdigitizer: version 4.5. 411:860. https:\/\/automeris.io\/WebPlotDigitizer Accesssed 10.01.2025"},{"key":"7382_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL, C\u00f4t\u00e9 P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280\u2013286","journal-title":"Ann Intern Med"},{"key":"7382_CR16","volume":"18","author":"NR Haddaway","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA (2022) PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev 18:e1230","journal-title":"Campbell Syst Rev"},{"key":"7382_CR17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"7382_CR18","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JAC (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443\u20133457","journal-title":"Stat Med"},{"key":"7382_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1536867X0900900202","volume":"9","author":"RM Harbord","year":"2009","unstructured":"Harbord RM, Harris RJ, Sterne JAC (2009) Updated tests for small-study effects in meta-analyses. Stata J 9:197\u2013210","journal-title":"Stata J"},{"key":"7382_CR20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"7382_CR21","doi-asserted-by":"crossref","first-page":"p500","DOI":"10.1201\/9781003107347","volume-title":"Doing meta-analysis with R: a hands-on guide","author":"M Harrer","year":"2021","unstructured":"Harrer M, Cuijpers P, Furukawa T, Ebert D (2021) Doing meta-analysis with R: a hands-on guide, 1st edn. Taylor & Francis, New York, p p500","edition":"1"},{"key":"7382_CR22","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2024","unstructured":"R Core Team (2024) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria"},{"key":"7382_CR23","unstructured":"Schwarzer G (2024) meta: general package for meta-analysis. R package. Guido Schwarzer, Medical Center \u2013 University of Freiburg, Germany. Available from: https:\/\/CRAN.R-project.org\/package=meta. Accessed 09.02.2025"},{"key":"7382_CR24","unstructured":"Harrer M, Cuijpers P, Furukawa T, Ebert DD (2019) dmetar: companion R package for the guide 'doing meta-analysis in R'. R package version 0.1.0. https:\/\/dmetar.protectlab.org\/.\u00a0 Accessed 09.02.2025"},{"key":"7382_CR25","doi-asserted-by":"publisher","unstructured":"Bates D, Maechler M, Bolker B, Walker S (2015) Fitting linear mixed-effects models using lme4. Journal of statistical software 67:1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01","DOI":"10.18637\/jss.v067.i01"},{"key":"7382_CR26","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13930","volume":"75","author":"SA AlKhater","year":"2021","unstructured":"AlKhater SA, Al Moaigel HM (2021) Clinical spectrum and outcome of immunoglobulin a vasculitis in children: a 10-year clinical study. Int J Clin Pract 75:e13930","journal-title":"Int J Clin Pract"},{"key":"7382_CR27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00467-022-05675-2","volume":"38","author":"B Avci","year":"2023","unstructured":"Avci B, Kurt T, Aydin F, Celikel E, Tekin ZE, Sezer M et al (2023) Association of Pediatric Vasculitis Activity Score with immunoglobulin a vasculitis with nephritis. Pediatr Nephrol 38:763\u2013770","journal-title":"Pediatr Nephrol"},{"key":"7382_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20369-3","volume":"12","author":"Y Bi","year":"2022","unstructured":"Bi Y, Quan W, Hao W, Sun R, Li L, Jiang C et al (2022) A simple nomogram for assessing the risk of IgA vasculitis nephritis in IgA vasculitis Asian pediatric patients. Sci Rep 12:16809","journal-title":"Sci Rep"},{"key":"7382_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-017-3972-3","volume":"37","author":"IM Buscatti","year":"2018","unstructured":"Buscatti IM, Casella BB, Aikawa NE, Watanabe A, Farhat SCL, Campos LMA et al (2018) Henoch-Sch\u00f6nlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center. Clin Rheumatol 37:1319\u20131324","journal-title":"Clin Rheumatol"},{"key":"7382_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10157-019-01726-5","volume":"23","author":"EK \u00c7akici","year":"2019","unstructured":"\u00c7akici EK, G\u00fcr G, Yazilita\u015f F, Ero\u011flu FK, G\u00fcng\u00f6r T, Arda N et al (2019) A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification. Clin Exp Nephrol 23:939\u2013947","journal-title":"Clin Exp Nephrol"},{"key":"7382_CR31","first-page":"1394","volume":"9","author":"NS Carucci","year":"2022","unstructured":"Carucci NS, La Barbera G, Peruzzi L, La Mazza A, Silipigni L, Alibrandi A et al (2022) Time of onset and risk factors of renal involvement in children with Henoch-Sch\u00f6nlein purpura: retrospective study. Children (Basel) 9:1394","journal-title":"Children (Basel)"},{"key":"7382_CR32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.35339\/ic.6.4.221-225","volume":"6","author":"K Chaika","year":"2019","unstructured":"Chaika K, Makieieva N (2019) Proinflammatory cytokines Il-8 and Tnf\u03b1 with Henoch-Schonlein purpura in children. Inter Collegas 6:221\u2013225","journal-title":"Inter Collegas"},{"key":"7382_CR33","first-page":"121","volume":"31","author":"J Chang","year":"2005","unstructured":"Chang J, Zhao HX, Lu JR, Yang LB, Liang D, Li HB et al (2005) Significances of changes of nitric oxide and endothelin-1 in plasma of children with Henoch-Schonlein\u2019s purprua. J Jilin Univ Med Ed 31:121\u2013123","journal-title":"J Jilin Univ Med Ed"},{"key":"7382_CR34","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15781","volume":"66","author":"B Chatpaitoon","year":"2024","unstructured":"Chatpaitoon B, Rianthavorn P, Chanakul A, Khaosut P (2024) Clinical characteristics and risk factors for kidney involvement in children with immunoglobulin A vasculitis. Pediatr Int 66:e15781","journal-title":"Pediatr Int"},{"key":"7382_CR35","first-page":"44","volume":"5","author":"B Danac\u0131","year":"2024","unstructured":"Danac\u0131 B, Ba\u015ftu\u011f F, Karak\u00fckc\u00fc \u00c7, \u00c7elik B, \u00c7ele\u011fen K (2024) Assessment of oxidative stress and plasma gelsolin levels in children with IgA vasculitis. J Pediatr Acad 5:44\u201349","journal-title":"J Pediatr Acad"},{"key":"7382_CR36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.32552\/2021.ActaMedica.585","volume":"52","author":"S Demir","year":"2021","unstructured":"Demir S, Candan C, Turhan P, Erg\u00fcven M (2021) Henoch Sch\u00f6nlein Purpura \/ Ig A vasculitis in children and risk factors for renal involvement. Acta Med 52:230\u2013238","journal-title":"Acta Med"},{"key":"7382_CR37","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.semarthrit.2020.09.006","volume":"50","author":"S Demir","year":"2020","unstructured":"Demir S, Kaplan O, Celebier M, Sag E, Bilginer Y, Lay I et al (2020) Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis. Semin Arthritis Rheum 50:1238\u20131244","journal-title":"Semin Arthritis Rheum"},{"key":"7382_CR38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5606\/ArchRheumatol.2018.6562","volume":"33","author":"B Demircio\u011flu Kili\u00e7","year":"2018","unstructured":"Demircio\u011flu Kili\u00e7 B, Kasap Demir B (2018) Determination of risk factors in children diagnosed with Henoch-Sch\u00f6nlein Purpura. Arch Rheumatol 33:395\u2013401","journal-title":"Arch Rheumatol"},{"key":"7382_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00296-010-1528-9","volume":"31","author":"I Dursun","year":"2011","unstructured":"Dursun I, Dusunsel R, Poyrazoglu HM, Gunduz Z, Patiroglu T, Ulger H et al (2011) Circulating endothelial microparticles in children with Henoch-Schonlein purpura; preliminary results. Rheumatol Int 31:1595\u20131600","journal-title":"Rheumatol Int"},{"key":"7382_CR40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jcla.21817","volume":"30","author":"AT Elmas","year":"2016","unstructured":"Elmas AT, Tabel Y (2016) Platelet counts in children with Henoch-Schonlein purpura-relationship to renal involvement. J Clin Lab Anal 30:71\u201374","journal-title":"J Clin Lab Anal"},{"key":"7382_CR41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/00325481.2019.1609814","volume":"131","author":"RMK Ekinci","year":"2019","unstructured":"Ekinci RMK, Balci S, Sari Gokay S, Yilmaz HL, Dogruel D, Altintas DU et al (2019) Do practical laboratory indices predict the outcomes of children with Henoch-Sch\u00f6nlein purpura? Postgrad Med 131:295\u2013298","journal-title":"Postgrad Med"},{"key":"7382_CR42","first-page":"269","volume":"7","author":"D Ery\u0131lmaz","year":"2016","unstructured":"Ery\u0131lmaz D, Ece A (2016) Evaluation of follow-up results in children with Henoch-Sch\u00f6nlein purpura. J Clin Exp Invest 7:269\u2013277","journal-title":"J Clin Exp Invest"},{"key":"7382_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-8-33","volume":"8","author":"S Fessatou","year":"2008","unstructured":"Fessatou S, Nicolaidou P, Gourgiotis D, Georgouli H, Douros K, Moustaki M et al (2008) Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura. BMC Pediatr 8:33","journal-title":"BMC Pediatr"},{"key":"7382_CR44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.36472\/msd.v5i7.262","volume":"2018","author":"A Fedakar","year":"2018","unstructured":"Fedakar A (2018) Henoch Sch\u00f6nlein purpura in children: clinical features and risk factors for renal involvement. Medical Science and Discovery 2018:267\u2013273","journal-title":"Medical Science and Discovery"},{"key":"7382_CR45","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.3390\/ijms25073795","volume":"25","author":"M Frkovic","year":"2024","unstructured":"Frkovic M, Turcic A, Gagro A, Srsen S, Frkovic SH, Rogic D et al (2024) Erythrocyte glutathione S-transferase activity as a sensitive marker of kidney function impairment in children with IgA vasculitis. Int J Mol Sci 25:3795","journal-title":"Int J Mol Sci"},{"key":"7382_CR46","volume":"10","author":"R Fu","year":"2022","unstructured":"Fu R, Yang M, Li Z, Kang Z, Xun M, Wang Y et al (2022) Risk assessment and prediction model of renal damage in childhood immunoglobulin A vasculitis. Front Pediatr 10:967249-NA","journal-title":"Front Pediatr"},{"key":"7382_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00431-013-2150-0","volume":"173","author":"W Ge","year":"2014","unstructured":"Ge W, Wang HL, Sun RP (2014) Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Sch\u00f6nlein purpura nephritis in children. Eur J Pediatr 173:213\u2013218","journal-title":"Eur J Pediatr"},{"key":"7382_CR48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4274\/jcp.2020.0034","volume":"18","author":"AU G\u00f6kceo\u011flu","year":"2020","unstructured":"G\u00f6kceo\u011flu AU, Sevim M, Abseyi SN (2020) Relationship between hematological parameters and clinic of patients diagnosed as IgA vasculitis. G\u00fcncel Pediatri 18:390\u2013402","journal-title":"G\u00fcncel Pediatri"},{"key":"7382_CR49","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1097\/MPH.0000000000002288","volume":"44","author":"T G\u00fcng\u00f6r","year":"2022","unstructured":"G\u00fcng\u00f6r T, \u00d6zdel S, \u00c7akici EK, Yazilita\u015f F, Ba\u011flan E, Karakaya D et al (2022) An assessment on the effectiveness of the immature granulocyte percentage in predicting internal organ involvement among children with Henoch-Sch\u00f6nlein purpura. J Pediatr Hematol Oncol 44:e413\u2013e417","journal-title":"J Pediatr Hematol Oncol"},{"key":"7382_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00467-004-1726-3","volume":"20","author":"TS Ha","year":"2005","unstructured":"Ha TS (2005) The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura. Pediatr Nephrol 20:149\u2013153","journal-title":"Pediatr Nephrol"},{"key":"7382_CR51","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.25011\/cim.v46i2.40274","volume":"46","author":"X Han","year":"2023","unstructured":"Han X, Xu P (2023) Risk due to elevated uric acid levels in children with Henoch-Schonlein Purpura. Clin Invest Med 46:E18-22","journal-title":"Clin Invest Med"},{"key":"7382_CR52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/adc.2009.182394","volume":"95","author":"O Jauhola","year":"2010","unstructured":"Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, H\u00f6ltt\u00e4 T et al (2010) Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 95:877\u2013882","journal-title":"Arch Dis Child"},{"key":"7382_CR53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3339\/jkspn.2017.21.2.61","volume":"21","author":"DY Jung","year":"2017","unstructured":"Jung DY, Kwon YR, Yu MH, Namgoong MK (2017) Clinical features and prognosis of Henoch-Sch\u00f6nlein Purpura in children and adults: a 13-year retrospective study at a single centre. Child Kidney Dis 21:61\u201368","journal-title":"Child Kidney Dis"},{"key":"7382_CR54","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/BF00441608","volume":"146","author":"H Kamitsuji","year":"1987","unstructured":"Kamitsuji H, Tani K, Yasui M, Taniguchi A, Taira K et al (1987) Activity of blood coagulation Factor XIII as a prognostic indicator in patients with Henoch-Sch\u00f6nlein Purpura. Eur J Pediatr 146:519\u2013523","journal-title":"Eur J Pediatr"},{"key":"7382_CR55","first-page":"172","volume":"21","author":"ZJ Kang","year":"2019","unstructured":"Kang ZJ, Liu B, Li ZH, Duan CR, Wu TH, Xun M et al (2019) Value of galactose-deficient IgA1 in the early diagnosis of Henoch-Sch\u00f6nlein purpura nephritis in children. Zhongguo Dang Dai Er Ke Za Zhi 21:172\u2013175","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"7382_CR56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MEG.0000000000000284","volume":"27","author":"A Kanik","year":"2015","unstructured":"Kanik A, Baran M, Ince FD, Cebeci O, Bozkurt M, Cavusoglu D et al (2015) Faecal calprotectin levels in children with Henoch-Sch\u00f6nlein purpura: is this a new marker for gastrointestinal involvement? Eur J Gastroenterol Hepatol 27:254\u2013258","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"7382_CR57","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/00325481.2020.1807161","volume":"133","author":"\u015eG Karada\u011f","year":"2021","unstructured":"Karada\u011f \u015eG, \u00c7akmak F, \u00c7il B, Tanatar A, S\u00f6nmez HE, K\u0131yak A et al (2021) The relevance of practical laboratory markers in predicting gastrointestinal and renal involvement in children with Henoch-Sch\u00f6nlein purpura. Postgrad Med 133:272\u2013277","journal-title":"Postgrad Med"},{"key":"7382_CR58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.15746\/sms.19.021","volume":"25","author":"M Kim","year":"2019","unstructured":"Kim M, Suh WS (2019) Clinical usefulness of neutrophil-lymphocyte ratio as a predictor of Henoch-Sch\u00f6nlein Nephritis. Soonchunhyang Med Sci 25:110\u2013116","journal-title":"Soonchunhyang Med Sci"},{"key":"7382_CR59","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jped.2021.01.008","volume":"97","author":"WK Kim","year":"2021","unstructured":"Kim WK, Kim CJ, Yang EM (2021) Risk factors for renal involvement in Henoch-Sch\u00f6nlein purpura. J Pediatr 97:646\u2013650","journal-title":"J Pediatr"},{"key":"7382_CR60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejr.2020.02.004","volume":"42","author":"M\u00d6 Ko\u00e7","year":"2020","unstructured":"Ko\u00e7 M\u00d6, Dursun H, Kural B, Hatipo\u011flu S (2020) Organ involvement in immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura) children: relation to immune profile. Egypt Rheumatol 42:219\u2013223","journal-title":"Egypt Rheumatol"},{"key":"7382_CR61","first-page":"505","volume":"39","author":"L Lei","year":"2018","unstructured":"Lei L, Zhou L, Cai B, Gan L, Gao Y, Jiang JJ (2018) Clinical characteristics of children Henoch-Sch\u00f6nlein purpura: report of 91 cases. Acad J Second Mil Univ 39:505\u2013509","journal-title":"Acad J Second Mil Univ"},{"key":"7382_CR62","first-page":"S204","volume":"94","author":"W Limpongsanurak","year":"2011","unstructured":"Limpongsanurak W, Kietkajornkul C, Singalavanija S (2011) Predictive factor of severe renal involvement in children with Henoch-Schoenlein purpura. J Med Assoc Thai 94:S204-208","journal-title":"J Med Assoc Thai"},{"key":"7382_CR63","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s11427-018-9544-0","volume":"62","author":"H Liu","year":"2019","unstructured":"Liu H, Cui W, Liu H, Zhang C (2019) Predicative value of urinary protein biomarkers on delayed renal involvement in children with Henoch-Sch\u00f6nlein purpura. Sci China Life Sci 62:1594\u20131596","journal-title":"Sci China Life Sci"},{"key":"7382_CR64","volume":"276","author":"L Liu","year":"2023","unstructured":"Liu L, Liu H, Zhu K, Zhang L, Yin X, Han L et al (2023) Proteome analysis reveals novel serum biomarkers for Henoch-Sch\u00f6nlein purpura in Chinese children. J Proteomics 276:104841","journal-title":"J Proteomics"},{"key":"7382_CR65","first-page":"3894","volume":"21","author":"DQ Ma","year":"2017","unstructured":"Ma DQ, Li Y, Han ZG, Zheng M, Xu N, Fan XJ (2017) Analysis on kidney injury-related clinical risk factors and evaluation on the therapeutic effects of hemoperfusion in children with Henoch-Schonlein purpura. Eur Rev Med Pharmacol Sci 21:3894\u20133899","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7382_CR66","volume":"108","author":"X Ma","year":"2022","unstructured":"Ma X, Sun Y, Wang D, Lin Y, Chang H (2022) Blood transthyretin for predicting immunoglobulin A vasculitis nephritis outcome in children. Int Immunopharmacol 108:108765","journal-title":"Int Immunopharmacol"},{"key":"7382_CR67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.26693\/jmbs04.06.171","volume":"4","author":"NI Makieieva","year":"2019","unstructured":"Makieieva NI, Chaika K (2019) Status of complement system in children with Henoch-Schonlein purpura. Ukra\u00efns\u2019kij \u017eurnal medicini, b\u00ecolog\u00ec\u00ef ta sportu 4:171\u2013177","journal-title":"Ukra\u00efns\u2019kij \u017eurnal medicini, b\u00ecolog\u00ec\u00ef ta sportu"},{"key":"7382_CR68","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/0300060514530879","volume":"42","author":"Y Mao","year":"2014","unstructured":"Mao Y, Yin L, Huang H, Zhou Z, Chen T, Zhou W (2014) Henoch-Schonlein purpura in 535 Chinese children: clinical features and risk factors for renal involvement. J Int Med Res 42:1043\u20131049","journal-title":"J Int Med Res"},{"key":"7382_CR69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314548","volume":"23","author":"J Marro","year":"2022","unstructured":"Marro J, Chetwynd AJ, Edwards S, Wright RD, Oni L (2022) Increased urinary IgA in paediatric IgA vasculitis nephritis. Int J Mol Sci 23:14548","journal-title":"Int J Mol Sci"},{"key":"7382_CR70","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.29271\/jcpsp.2024.10.1258","volume":"34","author":"S Min","year":"2024","unstructured":"Min S, Chen X, Wang D, Lin X, Jiang G (2024) Risk factors for renal involvement in childhood Henoch-Schonlein purpura (IgA vasculitis). J Coll Physicians Surg Pak 34:1258\u20131261","journal-title":"J Coll Physicians Surg Pak"},{"key":"7382_CR71","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s00467-002-0885-3","volume":"17","author":"A Muslu","year":"2002","unstructured":"Muslu A, Islek I, Gok F, Aliyazicioglu Y, Dagdemir A, Dundaroz R et al (2002) Endothelin levels in Henoch-Schonlein purpura. Pediatr Nephrol 17:920\u2013925","journal-title":"Pediatr Nephrol"},{"key":"7382_CR72","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4274\/buchd.galenos.2022.87533","volume":"12","author":"\u00d6 Akyol","year":"2022","unstructured":"Akyol \u00d6, Ertan P (2022) Predictive factors of organ involvement in childhood Henoch-Schonlein Purpura. J Dr Behcet Uz Child Hosp 12:120\u2013127","journal-title":"J Dr Behcet Uz Child Hosp"},{"key":"7382_CR73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4274\/haseki.4164","volume":"56","author":"A \u00d6zel","year":"2018","unstructured":"\u00d6zel A, Bostan Gayret \u00d6, Erol M, Yi\u011fit \u00d6, Mete F (2018) Are mean platelet volume and neutrophil-to- lymphocyte ratio valuable in the early detection of system involvements in Henoch-Sch\u00f6nlein purpura? Medical Bulletin of Haseki 56:279\u2013285","journal-title":"Medical Bulletin of Haseki"},{"key":"7382_CR74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188718","volume":"12","author":"E Pillebout","year":"2017","unstructured":"Pillebout E, Jamin A, Ayari H, Housset P, Pierre M, Sauvaget V et al (2017) Biomarkers of IgA Vasculitis Nephritis in children. PLoS One 12:e0188718","journal-title":"PLoS One"},{"key":"7382_CR75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1440-1797.2010.01360.x","volume":"16","author":"Y-H Qin","year":"2010","unstructured":"Qin Y-H, Zhou T-B, Lei F-Y, Huang W-F, Zhao Y-J, Lin F-Q (2010) Cut\u2010off values for serum matrix metalloproteinase\u20109: is there a threshold to predict renal involvement for Henoch\u2013Schonlein purpura in children? Nephrology (Carlton, Vic) 16:93\u201399","journal-title":"Nephrology (Carlton, Vic)"},{"key":"7382_CR76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00296-004-0452-2","volume":"25","author":"D Rigante","year":"2005","unstructured":"Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A (2005) Predictive factors of renal involvement or relapsing disease in children with Henoch-Schonlein purpura. Rheumatol Int 25:45\u201348","journal-title":"Rheumatol Int"},{"key":"7382_CR77","first-page":"1009","volume":"15","author":"L Ru","year":"2013","unstructured":"Ru L, Abudouhaer A, Guo YF (2013) Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis. Zhongguo Dang Dai Er Ke Za Zhi 15:1009\u20131013","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"7382_CR78","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000516765","volume":"238","author":"M Sestan","year":"2022","unstructured":"Sestan M, Srsen S, Kifer N, Sapina M, Batnozic Varga M, Ovuka A et al (2022) Persistence and severity of cutaneous manifestations in IgA Vasculitis is associated with development of IgA Vasculitis Nephritis in children. Dermatology 238:340\u2013346","journal-title":"Dermatology"},{"key":"7382_CR79","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1684\/ejd.2022.4207","volume":"32","author":"X Shen","year":"2022","unstructured":"Shen X, Zhang W, Li X, Lu H (2022) Association between serum IgG and Henoch-Sch\u00f6nlein purpura with renal involvement in children: a cross-sectional study. Eur J Dermatol 32:132\u2013134","journal-title":"Eur J Dermatol"},{"key":"7382_CR80","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/03009740510026841","volume":"35","author":"JI Shin","year":"2006","unstructured":"Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS (2006) Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schonlein purpura. Scand J Rheumatol 35:56\u201360","journal-title":"Scand J Rheumatol"},{"key":"7382_CR81","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1651-2227.1977.tb07943.x","volume":"66","author":"S Simil\u00e4","year":"1977","unstructured":"Simil\u00e4 S, Kouvalainen K, Lanning M (1977) Serum immunoglobulin levels in the course of anaphylactoid purpura in children. Acta Paediatr Scand 66:537\u2013540","journal-title":"Acta Paediatr Scand"},{"key":"7382_CR82","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1159\/000519665","volume":"238","author":"Z Song","year":"2022","unstructured":"Song Z, Nie Y, Yang L, Tao J (2022) Predicting severe renal and gastrointestinal involvement in childhood Immunoglobulin A vasculitis with routine laboratory parameters. Dermatology 238:745\u2013752","journal-title":"Dermatology"},{"key":"7382_CR83","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.intimp.2016.07.032","volume":"39","author":"Z Su","year":"2016","unstructured":"Su Z, Lv X, Liu Y, Zhang J, Guan J, Gai Z (2016) Circulating midkine in children with Henoch-Schonlein purpura: clinical implications. Int Immunopharmacol 39:246\u2013250","journal-title":"Int Immunopharmacol"},{"key":"7382_CR84","doi-asserted-by":"crossref","first-page":"114239","DOI":"10.18632\/oncotarget.23207","volume":"8","author":"L Sun","year":"2017","unstructured":"Sun L, Xie B, Zhang Q, Wang Y, Wang X, Gao B et al (2017) Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis children. Oncotarget 8:114239\u2013114250","journal-title":"Oncotarget"},{"key":"7382_CR85","doi-asserted-by":"crossref","first-page":"633","DOI":"10.46497\/ArchRheumatol.2023.9914","volume":"38","author":"EN Sunar Yayla","year":"2023","unstructured":"Sunar Yayla EN, Bakkaloglu SA (2023) Does age at disease onset affect the clinical presentation and outcome in children with Immunoglobulin A vasculitis? Arch Rheumatol 38:633\u2013641","journal-title":"Arch Rheumatol"},{"key":"7382_CR86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10157-020-01968-8","volume":"25","author":"M Tang","year":"2021","unstructured":"Tang M, Zhang X, Li X, Lei L, Zhang H, Ling C et al (2021) Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis. Clin Exp Nephrol 25:37\u201343","journal-title":"Clin Exp Nephrol"},{"key":"7382_CR87","first-page":"473","volume":"22","author":"B Wang","year":"2020","unstructured":"Wang B, Shao-Kuan FR, Dong C (2020) Expression and significance of follicular helper T cells and galactose-deficient IgA1 in children with Henoch-Sch\u00f6nlein purpura. Zhongguo Dang Dai Er Ke Za Zhi 22:473\u2013477","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"7382_CR88","doi-asserted-by":"crossref","first-page":"938","DOI":"10.21037\/tp-23-176","volume":"12","author":"J Wang","year":"2023","unstructured":"Wang J, Ye WP (2023) The comparisons of vitamin D3 levels in IgA vasculitis across different subgroups and healthy children: a comparative study. Transl Pediatr 12:938\u2013946","journal-title":"Transl Pediatr"},{"key":"7382_CR89","volume":"2019","author":"J Wu","year":"2019","unstructured":"Wu J, He L, Bai L, Tan L, Hu M (2019) Apolipoprotein m serum levels correlate with IgA vasculitis and IgA vasculitis nephritis. Dis Markers 2019:1825849","journal-title":"Dis Markers"},{"key":"7382_CR90","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.2147\/IJGM.S337437","volume":"14","author":"L Xi","year":"2021","unstructured":"Xi L, Xu S, Jiang Y, Su H, Sun Y, Wen Y et al (2021) Predictive value of laboratory indexes on renal involvement in children with Henoch-Sch\u00f6nlein purpura. Int J Gen Med 14:7951\u20137959","journal-title":"Int J Gen Med"},{"key":"7382_CR91","volume":"96","author":"H Xu","year":"2017","unstructured":"Xu H, Li W, Mao JH, Pan YX (2017) Association between red blood cell distribution width and Henoch-Schonlein purpura nephritis. Medicine (Baltimore) 96:e7091","journal-title":"Medicine (Baltimore)"},{"key":"7382_CR92","first-page":"139","volume":"118","author":"HI Yakut","year":"2020","unstructured":"Yakut HI, Kurt T, Uncu N, Cayci FS, Acar BC (2020) Predictive role of neutrophil to lymphocyte ratio and mean platelet volume in Henoch-Sch\u00f6nlein purpura related gastrointestinal and renal involvement. Arch Argent Pediatr 118:139\u2013142","journal-title":"Arch Argent Pediatr"},{"issue":"Pt A","key":"7382_CR93","volume":"142","author":"S Yu","year":"2024","unstructured":"Yu S, Zhang R, Lin Y, Lei K, Zhang J, Chang H (2024) Blood soluble CD89-IgA complex may be a potential biomarker for predicting multi-organ involvement, especially renal involvement in children with immunoglobulin A vasculitis. Int Immunopharmacol 142(Pt A):113063","journal-title":"Int Immunopharmacol"},{"key":"7382_CR94","first-page":"3924","volume":"15","author":"L Yuan","year":"2018","unstructured":"Yuan L, Wang Q, Zhang S, Zhang L (2018) Correlation between serum inflammatory factors TNF-\u03b1, IL-8, IL-10 and Henoch-Sch\u00f6nlein purpura with renal function impairment. Exp Ther Med 15:3924\u20133928","journal-title":"Exp Ther Med"},{"key":"7382_CR95","first-page":"292","volume":"19","author":"YD Zhang","year":"2017","unstructured":"Zhang YD, Dong QW, Li RM, Ji CY, Chu YT, Ma L et al (2017) Changes in 25-hydroxyvitamin D3 level in children with Henoch-Sch\u00f6nlein purpura. Zhongguo Dang Dai Er Ke Za Zhi 19:292\u2013295","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"7382_CR96","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.12677\/ACM.2022.12111496","volume":"12","author":"\u6708 \u5f20","year":"2022","unstructured":"\u5f20\u6708 (2022) Children in Liangshan Area of Sichuan Prov-ince with Henoch-Sch\u00f6nlein Purpura kidney damage risk factor analysis. Adv Clin Med 12:10383\u201310389","journal-title":"Adv Clin Med"},{"key":"7382_CR97","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00431-015-2601-x","volume":"175","author":"J Zhang","year":"2016","unstructured":"Zhang J, Zeng H, Wang N, Tian X, Dou W, Shi P (2016) Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Sch\u00f6nlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels. Eur J Pediatr 175:49\u201355","journal-title":"Eur J Pediatr"},{"key":"7382_CR98","volume":"29","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Yadav PK, Pan Y, Niu S, Zhang S, Wang H, Wang Z (2019) Analysis of 135 cases of pediatric Henoch-Sch\u00f6nlein purpura in Gansu, northwestern China. Innov J Pediatr 29:e90663","journal-title":"Innov J Pediatr"},{"key":"7382_CR99","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/09674845.2017.1368184","volume":"75","author":"X Zhu","year":"2018","unstructured":"Zhu X, Zhang M, Lan F, Wei H, He Q, Li S et al (2018) The relationship between red cell distribution width and the risk of Henoch-Sch\u00f6nlein purpura nephritis. Br J Biomed Sci 75:30\u201335","journal-title":"Br J Biomed Sci"},{"key":"7382_CR100","doi-asserted-by":"crossref","unstructured":"Zhu q, Liu J, He Y, \u738b \u7389, Wu J (2023) Comparison of clinical characteristics and complication predictors of IgA vasculitis between pediatric and adult patients in China. https:\/\/www.researchsquare.com\/article\/rs-3176138\/v1. Accessed 10.11.2024","DOI":"10.21203\/rs.3.rs-3176138\/v1"},{"key":"7382_CR101","doi-asserted-by":"publisher","unstructured":"Zhu L, Zhang C, Xiang R, Luo Y (2022) Correlations of leukotriene B4 and 25-hydroxyvitamin D3 levels with disease severity in children with Henoch-Schonlein purpura. Clinical laboratory, 68(8). https:\/\/doi.org\/10.7754\/Clin.Lab.2021.211030","DOI":"10.7754\/Clin.Lab.2021.211030"},{"key":"7382_CR102","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/1756-185X.13904","volume":"23","author":"K Dyga","year":"2020","unstructured":"Dyga K, Machura E, Swietochowska E, Szczepanska M (2020) Analysis of the association between kidney injury biomarkers concentration and nephritis in immunoglobulin A vasculitis: a pediatric cohort study. Int J Rheum Dis 23:1184\u20131193","journal-title":"Int J Rheum Dis"},{"key":"7382_CR103","first-page":"429","volume":"51","author":"M Anil","year":"2009","unstructured":"Anil M, Aksu N, Kara OD, Bal A, Anil AB, Yavascan O et al (2009) Henoch-Sch\u00f6nlein purpura in children from western Turkey: a retrospective analysis of 430 cases. The Turk J Pediatr 51:429\u2013436","journal-title":"The Turk J Pediatr"},{"key":"7382_CR104","volume":"76","author":"L Ma","year":"2019","unstructured":"Ma L, Zeng A, Chen B, Chen Y, Zhou R (2019) Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: a meta-analysis. Int Immunopharmacol 76:105949","journal-title":"Int Immunopharmacol"},{"key":"7382_CR105","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12933-024-02191-5","volume":"23","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wei R, Wang X, Zhang W, Li M, Ni T et al (2024) The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension. Cardiovasc Diabetol 23:117","journal-title":"Cardiovasc Diabetol"},{"key":"7382_CR106","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","volume":"111","author":"S Diem","year":"2017","unstructured":"Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W et al (2017) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 111:176\u2013181","journal-title":"Lung Cancer"},{"key":"7382_CR107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5578\/tt.202403838","volume":"72","author":"HG Kurt","year":"2024","unstructured":"Kurt HG, Akinci \u00d6zy\u00fcrek B, Erdo\u011fan Y, Aky\u00fcrek N (2024) Association of mean platelet volume (MPV), MPV\/PLATELET (PLT) ratio, and lymphocyte\/monocyte ratio (LMR) as poor prognostic factor in EGFR-mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitor. Tuberk Toraks 72:197\u2013207","journal-title":"Tuberk Toraks"},{"key":"7382_CR108","doi-asserted-by":"crossref","DOI":"10.5812\/ijp.6129","volume":"26","author":"M Erol","year":"2016","unstructured":"Erol M, Yigit O, Tasdemir M, Bostan Gayret O, Buke O, Gunes A et al (2016) Potential of serum and urinary matrix metalloproteinase-9 levels for the early detection of renal involvement in children with Henoch-Sch\u00f6nlein Purpura. Iran J Pediatr 26:e6129","journal-title":"Iran J Pediatr"},{"key":"7382_CR109","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00467-013-2740-0","volume":"29","author":"Y Fuentes","year":"2014","unstructured":"Fuentes Y, Hern\u00e1ndez AM, Garc\u00eda-Roca P, Valverde S, Vel\u00e1squez-Jones LF, Sosa G et al (2014) Urinary MCP-1\/creatinine in Henoch-Sch\u00f6nlein Purpura and its relationship with nephritis. Pediatr Nephrol 29:1047\u20131052","journal-title":"Pediatr Nephrol"},{"key":"7382_CR110","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00296-019-04274-z","volume":"39","author":"M Jaszczura","year":"2019","unstructured":"Jaszczura M, G\u00f3ra A, Grzywna-Rozenek E, Bar\u0107-Czarnecka M, Machura E (2019) Analysis of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and mean platelet volume to platelet count ratio in children with acute stage of immunoglobulin A vasculitis and assessment of their suitability for predicting the course of the disease. Rheumatol Int 39:869\u2013878","journal-title":"Rheumatol Int"},{"key":"7382_CR111","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00467-021-04950-y","volume":"37","author":"MC Hastings","year":"2022","unstructured":"Hastings MC, Rizk DV, Kiryluk K, Nelson R, Zahr RS, Novak J et al (2022) IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatr Nephrol 37:719\u2013733","journal-title":"Pediatr Nephrol"},{"key":"7382_CR112","first-page":"88","volume":"9","author":"HTB Saracoglu","year":"2024","unstructured":"Saracoglu HTB, Ko\u00e7yi\u011fit \u0130 (2024) Evaluation of the prognostic value of inflammatory biomarkers in immunoglobulin A nephropathy. J Anat Med Res 9:88\u201392","journal-title":"J Anat Med Res"},{"key":"7382_CR113","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211024828","volume":"13","author":"M Sestan","year":"2021","unstructured":"Sestan M, Kifer N, Frkovi\u0107 M, \u0160apina M, Sr\u0161en S, Varga MB et al (2021) Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis. Ther Adv Musculoskelet Dis 13:1759720X211024828","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"7382_CR114","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","volume":"22","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB et al (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22:1795\u20131803","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07382-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:54:23Z","timestamp":1792104863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07382-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":114,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["7382"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07382-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethical approval was required for this systematic review with meta-analysis, as all data were already published in peer-reviewed journals. No patients were involved in the design, conduct or interpretation of our study. The datasets used in this study can be found in the full-text articles included in the systematic review and meta-analysis.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}